IHL News: Incannex Announces Final Results from Phase 1 Clinical Trial Assessing Safety and Pharmacokinetics o - 2nd May 2023, 9:30pm

[annb0t]

Incannex Healthcare

Safety and Tolerability Results Safety and Tolerability Results

CBD Pharmacokinetic Results CBD Pharmacokinetic Results

Hydroxychloroquine Pharmacokinetic Results Hydroxychloroquine Pharmacokinetic Results

MELBOURNE, Australia, May 02, 2023 (GLOBE NEWSWIRE) -- Incannex Healthcare Limited (Nasdaq: IXHL) (ASX: IHL), (‘Incannex’ or the ‘Company’) a clinical-stage pharmaceutical company developing unique medicinal cannabinoid pharmaceutical products and ps...

>>> Read more: Incannex Announces Final Results from Phase 1 Clinical Trial Assessing Safety and Pharmacokinetics of IHL-675A